Microglia Development and Maturation and Its Implications for Induction of Microglia-Like Cells from Human iPSCs

Abstract

Microglia are resident immune cells of the central nervous system and play critical roles during the development, homeostasis, and pathologies of the brain. Originated from yolk sac erythromyeloid progenitors, microglia immigrate into the embryonic brain parenchyma to undergo final postnatal differentiation and maturation driven by distinct chemokines, cytokines, and growth factors. Among them, TGFβ1 is an important regulator of microglial functions, mediating homeostasis, anti-inflammation, and triggering the expression of microglial homeostatic signature genes. Since microglia studies are mainly based on rodent cells and the isolation of homeostatic microglia from human tissue is challenging, human-induced pluripotent stem cells have been successfully differentiated into microglia-like cells recently. However, employed differentiation protocols strongly vary regarding used cytokines and growth factors, culture conditions, time span, and cell yield. Moreover, the incomplete differentiation of human microglia can hamper the similarity to primary human microglia and dramatically influence the outcome of follow-up studies with these differentiated cells. This review summarizes the current knowledge of the molecular mechanisms driving rodent microglia differentiation in vivo, further compares published differentiation protocols, and highlights the potential of TGFβ as an essential maturation factor.

Role of ABCA7 in Human Health and in Alzheimer’s Disease

“…These cells can be differentiated into neurons to investigate not only neurogenesis but also Aβ production. It would be also possible to generate in vitro models of the BBB [ 91 ] or microglial cells [ 92 ] to further study Aβ clearance from CNS, and therefore to gain insight into the molecular role of ABCA7 in AD.…”

Enriched Environment Cues Suggest a New Strategy to Counteract Glioma: Engineered rAAV2-IL-15 Microglia Modulate the Tumor Microenvironment

“…In this paper, we investigated the possible therapeutic efficacy of the adoptive transfer of microglia, modified with the rAAV vector carrying IL-15, to mimic the EE effects on glioma. The possibility to exploit microglial cells intranasally delivered as a source of IL-15 directly in the tumor mass could be an attractive alternative for GBM patient treatment, due to the high potential for clinical translatability, as one can obtain the microglia starting from patients' iPSCs, as recently reported (46). The local delivery of cells as therapeutic carriers against glioma has produced encouraging results but encounters obstacles with regard to the repeatability and invasiveness of administration.…”

Microglia and Astrocyte Function and Communication: What Do We Know in Humans?

“…Genetic data has been invaluable in providing a greater understanding of microglia and their function in neurological conditions. Being derived from the early erythro-myeloid progenitors in the yolk sac ( Ginhoux et al, 2010 ), many genes contribute to their differentiation and role as immune cells within the CNS ( Wurm et al, 2021 ). As aging occurs, microglial gene expression changes and this might potentially explain why aging is the major contributor to disease risk in neurodegenerative conditions ( Olah et al, 2020 ).…”